Itau Unibanco Holding S.A. Sells 98 Shares of Intuitive Surgical, Inc. $ISRG

Itau Unibanco Holding S.A. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 55.1% in the first quarter, HoldingsChannel.com reports. The fund owned 80 shares of the medical equipment provider’s stock after selling 98 shares during the quarter. Itau Unibanco Holding S.A.’s holdings in Intuitive Surgical were worth $40,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of ISRG. Lansforsakringar Fondforvaltning AB publ raised its stake in Intuitive Surgical by 1.3% in the first quarter. Lansforsakringar Fondforvaltning AB publ now owns 212,203 shares of the medical equipment provider’s stock valued at $105,098,000 after purchasing an additional 2,714 shares in the last quarter. Next Century Growth Investors LLC raised its stake in Intuitive Surgical by 64.6% in the first quarter. Next Century Growth Investors LLC now owns 11,343 shares of the medical equipment provider’s stock valued at $5,618,000 after purchasing an additional 4,453 shares in the last quarter. Truvestments Capital LLC raised its stake in Intuitive Surgical by 19.1% in the first quarter. Truvestments Capital LLC now owns 2,200 shares of the medical equipment provider’s stock valued at $1,090,000 after purchasing an additional 353 shares in the last quarter. Silvant Capital Management LLC raised its stake in Intuitive Surgical by 0.3% in the first quarter. Silvant Capital Management LLC now owns 86,287 shares of the medical equipment provider’s stock valued at $42,735,000 after purchasing an additional 252 shares in the last quarter. Finally, CreativeOne Wealth LLC raised its stake in Intuitive Surgical by 9.7% in the first quarter. CreativeOne Wealth LLC now owns 5,472 shares of the medical equipment provider’s stock valued at $2,710,000 after purchasing an additional 486 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ISRG. Piper Sandler reaffirmed an “overweight” rating and issued a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Evercore ISI boosted their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a report on Tuesday, July 8th. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Citigroup reissued a “buy” rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, July 26th. Thirteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Gary S. Guthart sold 7,893 shares of the company’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total value of $3,935,765.52. Following the completion of the transaction, the insider owned 13,187 shares of the company’s stock, valued at $6,575,565.68. This represents a 37.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,839 shares of company stock valued at $7,896,972 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 0.6%

Shares of ISRG opened at $473.84 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The business has a 50-day simple moving average of $501.17 and a two-hundred day simple moving average of $518.82. The stock has a market cap of $169.86 billion, a PE ratio of 66.09, a PEG ratio of 4.94 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the prior year, the firm earned $1.78 EPS. The business’s revenue for the quarter was up 21.4% compared to the same quarter last year. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.